AbbVie (ABBV) Enterprise Value (2016 - 2025)
Historic Enterprise Value for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to -$5.6 billion.
- AbbVie's Enterprise Value rose 2232.96% to -$5.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.6 billion, marking a year-over-year increase of 2232.96%. This contributed to the annual value of -$5.5 billion for FY2024, which is 5683.54% up from last year.
- As of Q3 2025, AbbVie's Enterprise Value stood at -$5.6 billion, which was up 2232.96% from -$6.4 billion recorded in Q2 2025.
- Over the past 5 years, AbbVie's Enterprise Value peaked at -$5.1 billion during Q1 2025, and registered a low of -$18.0 billion during Q1 2024.
- For the 5-year period, AbbVie's Enterprise Value averaged around -$9.5 billion, with its median value being -$9.2 billion (2022).
- As far as peak fluctuations go, AbbVie's Enterprise Value surged by 7629.19% in 2021, and later plummeted by 16937.1% in 2024.
- Quarter analysis of 5 years shows AbbVie's Enterprise Value stood at -$9.8 billion in 2021, then rose by 6.18% to -$9.2 billion in 2022, then tumbled by 38.96% to -$12.8 billion in 2023, then skyrocketed by 56.84% to -$5.5 billion in 2024, then fell by 2.03% to -$5.6 billion in 2025.
- Its Enterprise Value was -$5.6 billion in Q3 2025, compared to -$6.4 billion in Q2 2025 and -$5.1 billion in Q1 2025.